Subcutaneous semaglutide vs. placebo as adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity

What The Study Did:


This randomized clinical trial compares the effects of once-weekly subcutaneous semaglutide versussplacebo for weight management as an adjunct to intensive behavioral therapy with initial low-calorie diet in adults with overweight or obesity.

Authors:


Thomas A. Wadden, Ph.D., of the University of Pennsylvania in Philadelphia, is the corresponding author.

To access the embargoed study:


Visit our For The Media website at this link


https:/

/

media.

jamanetwork.

com/

(doi:10.1001/jama.2021.1831)

Editor’s Note:

The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

###

Media advisory:


The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article


This link will be live at the embargo time


https:/

/

jamanetwork.

com/

journals/

jama/

fullarticle/

10.

1001/

jama.

2021.

1831?guestAccessKey=

5d38b335-f31a-4bd8-8fbf-167360ac109d&utm_source=

For_The_Media&utm_medium=

referral&utm_campaign=

ftm_links&utm_content=

tfl&utm_term=

022421